What will really matter in the long run? That’s the question we tackle each year as we compile this annual list. The 2025 edition will be published in January. Here’s what won’t be on it. AI advances ...
The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from legally selling cheap knockoff versions.